On its merger with
Completion subject to customary conditions (including regulatory approvals)
In September 2023, Markerstudy Group (“Markerstudy”) agreed to merge with Atlanta Group (“Atlanta”), the personal lines broking business of the Ardonagh Group (“Ardonagh”).
Continuum Advisory Partners acted as exclusive Financial Advisor to Markerstudy and its shareholders, Pollen Street Capital.
The merger of Markerstudy and Atlanta will create a major new player in the UK insurance market. The combined business will provide a wide range of insurance products and will transact over £3 billion in annual Gross Written Premium.
The transaction values Atlanta at £1.2 billion and will be funded by a new investment led by Pollen Street Capital and Bain Capital Special Situations. Ardonagh and its related parties will receive a combination of cash and a substantial minority equity stake in the combined business. Key Atlanta executives will join the Markerstudy management team as senior executives in the combined business.
The transaction highlights Continuum’s specialist expertise in the insurance sector and advising on complex transactions involving financial sponsors.
Completion of the transaction remains subject to customary conditions (including regulatory approvals).
To stay informed, please visit our contact page to subscribe to Continuum deal updates and news.
Continuum Advisory Partners Limited ("Continuum") is incorporated and registered in England and Wales with registered no. 14189636. Continuum is an appointed representative (Firm Reference Number 979923) of Kroll Securities Ltd., which is authorised and regulated by the Financial Conduct Authority.